Literature DB >> 24026034

Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells.

Caihong Tan1, Xiaoqiang Qian, Rongdi Jia, Min Wu, Zhongqin Liang.   

Abstract

Non-small cell lung carcinoma (NSCLC) is one of the most refractory cancers in the clinic; it is insensitive to chemotherapy and is usually excised. However, screening natural compounds from herbs is also considered a possible method for its therapy. In the present study, we investigated whether matrine, a natural compound isolated from Sophora flavescens Ait. and exerting an inhibitory effect on lung cancer cells, also indicates inhibition on NSCLC cells and elucidated its molecular mechanism. Firstly, it is confirmed that matrine induces apoptosis of human NSCLC cells with anti-apoptotic factors inhibited and dependent on caspase activity. In addition, we found that matrine increases the phosphorylation of p38 but not its total protein, and inhibition of the p38 pathway with SB202190 partially prevents matrine-induced apoptosis. Furthermore, matrine generates reactive oxygen species (ROS) in a dose- and time-dependent manner, which is reversed by pretreatment with N-acetyl-L-cysteine (NAC). Additionally, inhibition of cell proliferation and increase of phosphorylation of p38 was also partially reversed by NAC. Collectively, matrine activates p38 pathway leading to a caspase-dependent apoptosis by inducing generation of ROS in NSCLC cells and may be a potential chemical for NSCLC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026034     DOI: 10.3892/or.2013.2727

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  23 in total

1.  Matrine suppresses invasion and metastasis of NCI-H1299 cells by enhancing microRNA-133a expression.

Authors:  Hehe Liao; Xixi Zhao; Jinkun Qu; Jia Zhang; Hui Cai
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Role and mechanism of Sophoridine on proliferation inhibition in human glioma U87MG cell line.

Authors:  Wen-Xin Wang; Zheng-Hui Sun; Han-Men Chen; Bai-Nan Xu; Fu-Yu Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Synthesis, biological evaluation and mechanism studies of matrine derivatives as anticancer agents.

Authors:  Lihe Jiang; Lichuan Wu; Fangfang Yang; Nadin Almosnid; Xu Liu; Jun Jiang; Elliot Altman; Lisheng Wang; Ying Gao
Journal:  Oncol Lett       Date:  2017-06-23       Impact factor: 2.967

4.  [Matrine inhibits proliferation and promotes autophagy and apoptosis in non-small cell lung cancer cells by deactivating PI3K/AKT/mTOR pathway].

Authors:  Yanmei Hao; Hongmei Yin; Chaomang Zhu; Feng Li; Yingjie Zhang; Yuyun Li; Xiaojing Wang; Duojie Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

5.  Matrine promotes the efficacy and safety of platinum-based doublet chemotherapy for advanced non-small cell lung cancer.

Authors:  Biaoxue Rong; Chongchong Zhao; Wenlong Gao; Shuanying Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 6.  Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review.

Authors:  Yingda Lin; Qiu Du; Fuming He; Ling Wu; Yuan Xu
Journal:  Drug Des Devel Ther       Date:  2022-03-01       Impact factor: 4.162

7.  Antioxidant activity and protective effect of methyl gallate against t-BHP induced oxidative stress through inhibiting ROS production.

Authors:  Bo-Im Ryu; Ki-Tae Kim
Journal:  Food Sci Biotechnol       Date:  2022-06-27       Impact factor: 3.231

Review 8.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

9.  Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77.

Authors:  Yuhao Luo; Mridul Roy; Xiaojuan Xiao; Shuming Sun; Long Liang; Huiyong Chen; Yin Fu; Yang Sun; Min Zhu; Mao Ye; Jing Liu
Journal:  Tumour Biol       Date:  2014-12-07

10.  Matrine attenuates focal cerebral ischemic injury by improving antioxidant activity and inhibiting apoptosis in mice.

Authors:  Peng Zhao; Ru Zhou; Xiao-Yun Zhu; Yin-Ju Hao; Nan Li; Jie Wang; Yang Niu; Tao Sun; Yu-Xiang Li; Jian-Qiang Yu
Journal:  Int J Mol Med       Date:  2015-06-24       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.